Humacyte holds 2024 annual meeting; re-elects six directors and ratifies PwC as auditor

Humacyte, Inc.

John P. Bamforth, Emery N. Brown, Michael T. Constantino, Keith Anthony Jones, Laura E. Niklason, Susan Windham-Bannister elected as Class III directors.
Bamforth and Jones resigned and were immediately reappointed as Class II directors to rebalance board to four directors per class.
Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2024: 69,075,479 for, 883,816 against, 72,146 abstain.
Quorum achieved with 70,031,441 shares (58.8% of outstanding) present.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.